Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when PCVX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: PCVX Vaxcyte, Inc. 8-K

Vaxcyte reports Q1 2026 financial results

Filed May 6, 2026 · Period ending May 6, 2026 · ~1 min read

1 key change 1 section

Key Changes

  • medium

    Company announced first quarter 2026 earnings via press release on May 6, 2026. Actual financial figures are in the attached exhibit rather than the 8-K body.

    Item 2.02 — Results of Operations and Financial Condition verify on EDGAR →

Summary

Vaxcyte filed a routine quarterly earnings announcement for the period ended March 31, 2026. This is a standard Item 2.02 disclosure that biotech companies use to furnish financial results to the market. The 8-K itself serves as a wrapper; investors should review the attached press release exhibit for the actual revenue, cash position, R&D spend, and any pipeline updates the company chose to highlight.

For a clinical-stage vaccine developer like Vaxcyte, quarterly filings typically matter most when they reveal changes in cash runway or trial timelines. Watch the press release for any updates on the company's pneumococcal and other vaccine programs, as well as guidance on how long current cash reserves will fund operations.

Section-by-Section Diff

Event · Item 2.02 — Results of Operations and Financial Condition

~70 words

Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.

1 Added
Added Q1 2026 financial results medium

Added in current filing · verify on EDGAR →

On May 6, 2026, Vaxcyte, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2026.

Vaxcyte disclosed its first quarter 2026 financial results through a press release. The 8-K itself does not contain the actual financial figures, which are provided in the referenced press release exhibit. This is a routine earnings announcement filing.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Jun 17, 2026 · How we verify